LivingGLP1
Study S001949

Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients

Registration

Registration
NCT01473147
Acronym
AGAC2
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
COMPLETED
Enrollment
51
Start
2011-10
Primary completion
2013-06
Lead sponsor
Chang Gung Memorial Hospital
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:Exenatide; DRUG:Normal saline
Results posted
FALSE

Registered primary outcomes

  • Mean amplitude of glycaemic excursions (MAGE) [During 6-day treatment course]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.